Twist Bioscience

YTD

ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC.

CEO

Emily Marine Leproust

CEOEmily Marine Leproust

Employees

979

Employees979

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

979

Employees979

TWST Key Statistics

Market cap

10.84B

Market cap10.84B

Price-Earnings ratio

-74.57

Price-Earnings ratio-74.57

Dividend yield

—

Dividend yield—

Average volume

2.02M

Average volume2.02M

High today

$170.66

High today$170.66

Low today

$163.15

Low today$163.15

Open price

$165.83

Open price$165.83

Volume

2.30M

Volume2.30M

52 Week high

$170.66

52 Week high$170.66

52 Week low

$23.30

52 Week low$23.30

Stock Snapshot

With a market cap of 10.84B, Twist Bioscience(TWST) trades at $164.60. The stock has a price-to-earnings ratio of -74.57.

On 2026-09-22, Twist Bioscience(TWST) stock traded between a low of $163.15 and a high of $170.66. Shares are currently priced at $164.60, which is +0.9% above the low and -3.6% below the high.

The Twist Bioscience(TWST)'s current trading volume is 2.3M, compared to an average daily volume of 2.02M.

During the past year, Twist Bioscience(TWST) stock moved between $23.30 at its lowest and $170.66 at its peak.

TWST News

Investing.com 23h

Twist Bioscience CEO Emily Leproust sells $56.3m in company stock - Investing.com

...

Simply Wall St 3d

Twist Bioscience Stock Could Be 16% Undervalued On DNA Synthesis Market Outlook

has seen its share price move sharply in recent years, which puts the spotlight squarely on one question for investors who care about cash flows. Is the current...

TipRanks 4d

Twist Bioscience Rated Sell as Analyst Cites Limited Strategic Upside from Lilly TuneLab Deal; $45 Price Target Reaffirmed

Analyst Hamed Khorsand from BWS Financial maintained a Sell rating on Twist Bioscience and keeping the price target at $45.00. Hamed Khorsand has given his Sel...

Analyst ratings

75%

of 12 ratings

Buy

75%

Hold

16.7%

Sell

8.3%

More TWST News

Benzinga 6d

Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem

Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli...

TipRanks 6d

Twist Bioscience enters agreement with Lilly TuneLab

Twist Bioscience Corporation (TWST) announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (L...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

IonQ

Taiwan Semiconductor Manu…

AMD

Robinhood Markets

Rocket Lab Corporation

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.